Page 341 - HIVMED_v21_i1.indb

Page 7 of 7 Original Research

18. Goh BK, Chan RK, Sen P, et al. Spectrum of skin disorders in human 26. Cedeno-Laurent F, Gómez-Flores M, Mendez N, et al. New insights into HIV-1-
immunodeficiency virus-infected patients in Singapore and the relationship to primary skin disorders. J Int AIDS Soc. 2011;14(1):5. https://doi.org/10.1186/1758-
CD4 lymphocyte counts. Int J Dermatol. 2007;46(7):695–699. https://doi. 2652-14-5
org/10.1111/j.1365-4632.2007.03164.x 27. Zancanaro PCQ, McGirt LY, Mamelak AJ, Nguyen RHN, Martins CR. Cutaneous
19. Mbuagbaw J, Eyong I, Alemnji G, Mpoudi N, Same-Ekobo A. Patterns of skin manifestations of HIV in the era of highly active antiretroviral therapy: An
manifestations and their relationships with CD4 counts among HIV/AIDS patients institutional urban clinic experience. J Am Acad Dermatol. 2006;54(4):581–588.
in Cameroon. Int J Dermatol. 2006;45(3):280–284. https://doi.org/10. https://doi.org/10.1016/j.jaad.2005.12.030
1111/j.1365-4632.2004.02529.x
20. Kore SD, Kanwar AJ, Vinay K, Wanchu A. Pattern of mucocutaneous manifestations 28. Guiguet M, Boué F, Cadranel J, Lang JM, Rosenthal E, Costagliola D. Effect of
in human immunodeficiency virus-positive patients in North India. Indian J Sex immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of
Transm Dis. 2013;34(1):19–24. https://doi.org/10.4103/0253-7184.112865 individual malignancies (FHDH-ANRS CO4): A prospective cohort study. Lancet
Oncol. 2009;10(12):1152–1159. https://doi.org/10.1016/S1470-2045(09)
21. Prabhakaran N, Jaisankar TJ, Hamide A, Malathi M, Kumari R, Thappa DM. Effect 70282-7
of antiretroviral therapy on mucocutaneous manifestations among human
immunodeficiency virus-infected patients in a tertiary care centre in South India. 29. Cameron MC, Lee E, Hibler BP, et al. Basal cell carcinoma epidemiology;
Indian J Sex Transm Dis. 2015;36(2):166–173. https://doi.org/10.4103/0253- pathophysiology; clinical and histological subtypes; and disease associations. J Am
7184.167160 Acad Dermatol. 2019;80(2):303–317. https://doi.org/10.1016/j.jaad.2018.03.060
22. Punyaratabandhu P, Prasithsirikul W, Jirachanakul P. Skin manifestation of Thai HIV 30. Vasudevan B, Sagar A, Bahal A, Mohanty AP. Cutaneous manifestations of HIV – A
infected patients in HAART era. J Med Assoc Thai. 2012;95(4):497–504. detailed study of morphological variants, markers of advanced disease, and the
23. Resneck JS, Van Beek M, Furmanski L, et al. Etiology of pruritic papular eruption changing spectrum. Armed Forces Med J India. 2012;68(1):20–27. https://doi.
with HIV infection in Uganda. JAMA. 2004;292(21):2614–2621. https://doi. org/10.1016/S0377-1237(11)60122-6
org/10.1001/jama.292.21.2614 31. Johnson LF, Mossong J, Dorrington RE, et al. Life expectancies of South African
24. Boonchai W, Laohasrisakul R, Manonukul J, Kulthanan K. Pruritic papular eruption in adults starting antiretroviral treatment: Collaborative analysis of cohort studies.
HIV seropositive patients: A cutaneous marker for immunosuppression. Int J PLoS Med. 2013;10(4):e1001418. https://doi.org/10.1371/journal.pmed.
Dermatol. 1999;38(5):348–350. https://doi.org/10.1046/j.1365-4362.1999.00694.x 1001418
25. Chua SL, Amerson EH, Leslie KS, et al. Factors associated with pruritic papular 32. Stinson K, Goemaere E, Coetzee D, et al. Cohort profile: The Khayelitsha
eruption of human immunodeficiency virus infection in the antiretroviral therapy antiretroviral programme, Cape Town, South Africa. Int J Epidemiol.
era. Br J Dermatol. 2014;170(4):832–839. https://doi.org/10.1111/bjd.12721 2017;46(2):e21. https://doi.org/10.1093/ije/dyw057

http://www.sajhivmed.org.za 333 Open Access